234 related articles for article (PubMed ID: 12872447)
1. Prognostic significance of p21 and p53 expression in gastric cancer.
Seo YH; Joo YE; Choi SK; Rew JS; Park CS; Kim SJ
Korean J Intern Med; 2003 Jun; 18(2):98-103. PubMed ID: 12872447
[TBL] [Abstract][Full Text] [Related]
2. [Expression of cyclin dependent kinase inhibitors of KIP family in gastric cancer].
Lee SJ; Joo YE; Kim HS; Choi SK; Rew JS; Park CS; Kim SJ
Korean J Gastroenterol; 2005 Aug; 46(2):84-93. PubMed ID: 16118517
[TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients.
Al-Moundhri MS; Nirmala V; Al-Hadabi I; Al-Mawaly K; Burney I; Al-Nabhani M; Thomas V; Ganguly SS; Grant C
J Surg Oncol; 2005 Sep; 91(4):243-52. PubMed ID: 16121348
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of p21WAF1/CIP1, p27Kip1, p53 and E-cadherin expression in gastric cancer.
Gamboa-Dominguez A; Seidl S; Reyes-Gutierrez E; Hermannstädter C; Quintanilla-Martinez L; Busch R; Höfler H; Fend F; Luber B
J Clin Pathol; 2007 Jul; 60(7):756-61. PubMed ID: 17483253
[TBL] [Abstract][Full Text] [Related]
5. The clinical significance of p53, p21, and p27 expressions in rectal carcinoma.
Lebe B; Sarioğlu S; Sökmen S; Ellidokuz H; Füzün M; Küpelioğlu A
Appl Immunohistochem Mol Morphol; 2005 Mar; 13(1):38-44. PubMed ID: 15722792
[TBL] [Abstract][Full Text] [Related]
6. p21 expression is a prognostic factor in patients with p53-negative gastric cancer.
Xiangming C; Hokita S; Natsugoe S; Tanabe G; Baba M; Takao S; Kuroshima K; Aikou T
Cancer Lett; 2000 Feb; 148(2):181-8. PubMed ID: 10695995
[TBL] [Abstract][Full Text] [Related]
7. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058
[TBL] [Abstract][Full Text] [Related]
8. [Expression and significance of cell cycle regulators in gastric carcinoma].
Wu JF; Shao JC; Wang DB; Qin R; Zhang H
Ai Zheng; 2005 Feb; 24(2):175-9. PubMed ID: 15694028
[TBL] [Abstract][Full Text] [Related]
9. The overexpression of c-met as a prognostic indicator for gastric carcinoma compared to p53 and p21 nuclear accumulation.
Drebber U; Baldus SE; Nolden B; Grass G; Bollschweiler E; Dienes HP; Hölscher AH; Mönig SP
Oncol Rep; 2008 Jun; 19(6):1477-83. PubMed ID: 18497953
[TBL] [Abstract][Full Text] [Related]
10. Expression of p21 (waf1/cip1/sdi1), but not p53 protein, is a factor in the survival of patients with advanced gastric carcinoma.
Gomyo Y; Ikeda M; Osaki M; Tatebe S; Tsujitani S; Ikeguchi M; Kaibara N; Ito H
Cancer; 1997 Jun; 79(11):2067-72. PubMed ID: 9179052
[TBL] [Abstract][Full Text] [Related]
11. Expression of p21(Wafl/Cip1), p57(Kip2) and HER2/neu in patients with gallbladder cancer.
Puhalla H; Wrba F; Kandioler D; Lehnert M; Huynh A; Gruenberger T; Tamandl D; Filipits M
Anticancer Res; 2007; 27(3B):1679-84. PubMed ID: 17595796
[TBL] [Abstract][Full Text] [Related]
12. Expression of p53 and p21 are independent prognostic factors in patients with serosal invasion by gastric carcinoma.
Ikeguchi M; Saito H; Katano K; Tsujitani S; Maeta M; Kaibara N
Dig Dis Sci; 1998 May; 43(5):964-70. PubMed ID: 9590408
[TBL] [Abstract][Full Text] [Related]
13. Combined evaluation of expressions of p53 and p21 proteins as prognostic factors for patients with gastric carcinoma.
Okuyama T; Maehara Y; Kabashima A; Takahashi I; Kakeji Y; Sugimachi K
Oncology; 2002; 63(4):353-61. PubMed ID: 12417790
[TBL] [Abstract][Full Text] [Related]
14. p53 accumulation and mutation are prognostic indicators of poor survival in human gastric carcinoma.
Lim BH; Soong R; Grieu F; Robbins PD; House AK; Iacopetta BJ
Int J Cancer; 1996 Jun; 69(3):200-4. PubMed ID: 8682588
[TBL] [Abstract][Full Text] [Related]
15. The expression of p53, p21 and TGF beta 1 in gastric carcinoma.
Aoyagi K; Koufuji K; Yano S; Murakami N; Miyagi M; Koga A; Takeda J; Shirouzu K
Kurume Med J; 2003; 50(1-2):1-7. PubMed ID: 12971256
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of cyclin E and p53 expression in gastric carcinoma.
Sakaguchi T; Watanabe A; Sawada H; Yamada Y; Yamashita J; Matsuda M; Nakajima M; Miwa T; Hirao T; Nakano H
Cancer; 1998 Apr; 82(7):1238-43. PubMed ID: 9529014
[TBL] [Abstract][Full Text] [Related]
17. A combination analysis of p53 and p21 in gastric carcinoma as a strong indicator for prognosis.
Ogawa M; Onoda N; Maeda K; Kato Y; Nakata B; Kang SM; Sowa M; Hirakawa K
Int J Mol Med; 2001 May; 7(5):479-83. PubMed ID: 11295107
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD24, p21, p53, and c-myc in alpha-fetoprotein-producing gastric cancer: Correlation with clinicopathologic characteristics and survival.
Liu X; Yu H; Cai H; Wang Y
J Surg Oncol; 2014 Jun; 109(8):859-64. PubMed ID: 24619835
[TBL] [Abstract][Full Text] [Related]
19. Relationship between the long-term effects of intraperitoneal chemotherapy and the expression of p53 and p21 in patients with gastric carcinoma at stage IIIa and stage IIIb.
Ikeguchi M; Saito H; Katano K; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
Int Surg; 1997; 82(2):170-4. PubMed ID: 9331847
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the prognostic value of a panel of tissue tumor markers and established clinicopathological factors in patients with gastric cancer.
Wiksten JP; Lundin J; Nordling S; Kokkola A; Haglund C
Anticancer Res; 2008; 28(4C):2279-87. PubMed ID: 18751407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
